DAVID GRAHAM to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications DAVID GRAHAM has written about Platelet Aggregation Inhibitors.
Connection Strength
0.438
-
Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage. Scand J Gastroenterol. 2010 Mar; 45(3):292-8.
Score: 0.274
-
Evaluation of the benefits and risks of low-dose aspirin in the secondary prevention of cardiovascular and cerebrovascular events. Arch Intern Med. 2002 Oct 28; 162(19):2197-202.
Score: 0.165